Clinical outcomes in high-risk patients with hypertrophic cardiomyopathy receiving implantable cardioverter-defibrillators for primary prevention in china
Event: EHRA 2025
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias
The prognostic benefit of conduction system pacing over right ventricular pacing in patients with atrial fibrillation: a retrospective cohort study
Event: EHRA 2025
Topic: Heart Failure in Atrial Fibrillation
Session: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias
Exploring implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy patients: frequency, risk factors, and the link to future radiofrequency ablation
Event: EHRA 2025
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias
The combined impact of timing for implantable cardioverter-defibrillator implantation and appropriate ICD therapy on outcomes in hypertrophic cardiomyopathy patients
Event: EHRA 2025
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias
